EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Efficacy of dorzolamide to reduce retinal thickness after photocoagulation, in diabetic macular edema1

Virgilio Lima-Gómez, Diana Alejandra Bermúdez-Zapata, Dulce Milagros Razo Blanco-Hernández

Cirugía y Cirujanos (English Edition) · 2015

DOI: 10.1016/j.circen.2014.06.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cirugía y Cirujanos (English Edition), 2015. Verfasst von Virgilio Lima-Gómez und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Focal photocoagulation interrupts vascular leakage in diabetic macular oedema, and allows the retinal pigment epithelium to withdraw fluid that thickens the retina; this mechanism could be enhanced by dorzolamide, a topical carbonic anhydrase inhibitor.

Objective

To determine the efficacy of dorzolamide compared to placebo, in reducing retinal thickness after focal photocoagulation in eyes with diabetic macular oedema. Material and methods Experimental, comparative, prospective, longitudinal, double blind study in diabetics with focal macular oedema treated with photocoagulation. Treated eyes were randomly assigned three weeks after the procedure to receive dorzolamide (group 1) or placebo (group 2), three times daily for three weeks. Means of visual acuity, centre point thickness and macular volume were compared 3 and 6 weeks after photocoagulation within groups (Wilcoxon t) and between groups (Mann-Whitney-U).

Results

Sixty-nine eyes form patients aged 58.3 ± 8.3 years; 37 were assigned to group 1 and 42 to group 2. Mean centre point thickness changed from 178.4 ± 34 μm to 170 ± 29.1 μm in group 1 (p = 0.04), and from 179.2 ± 22.4 μm to 178.6 ± 20.8 μm in group 2 (p = 0.07); mean macular volume changed from 7.63 ± 0.52 mm 3 to 7.50 ± 0.50 mm 3 in group 1 (p = 0.002) and from 7.82 ± 0.43 mm 3 to 7.76 ± 0.42 mm 3 in group 2 (p = 0.013).

Conclusions

The efficacy of dorzolamide was higher than that of placebo in reducing retinal thickness after focal photocoagulation in diabetics with macular oedema.

Zitieren

APA

Lima-Gómez, V., Bermúdez-Zapata, D. A., & Blanco-Hernández, D. M. R. (2015). Efficacy of dorzolamide to reduce retinal thickness after photocoagulation, in diabetic macular edema1. Cirugía y Cirujanos (English Edition). https://doi.org/10.1016/j.circen.2014.06.001

Vancouver

Lima-Gómez V, Bermúdez-Zapata DA, Blanco-Hernández DMR. Efficacy of dorzolamide to reduce retinal thickness after photocoagulation, in diabetic macular edema1. Cirugía y Cirujanos (English Edition). 2015. doi:10.1016/j.circen.2014.06.001

BibTeX
@article{LimaGmez2015,
  author = {Lima-Gómez, Virgilio and Bermúdez-Zapata, Diana Alejandra and Blanco-Hernández, Dulce Milagros Razo},
  title = {Efficacy of dorzolamide to reduce retinal thickness after photocoagulation, in diabetic macular edema1},
  journal = {Cirugía y Cirujanos (English Edition)},
  year = {2015},
  doi = {10.1016/j.circen.2014.06.001}
}
Kostenlos starten →